- Home
- BMBL vs AURA Comparison
BMBL vs AURA Comparison
Compare BMBL & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMBL
- AURA
- Stock Information
- Founded
- BMBL 2014
- AURA 2007
- Country
- BMBL United States
- AURA United States
- Employees
- BMBL N/A
- AURA N/A
- Industry
- BMBL Computer Software: Prepackaged Software
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- BMBL Technology
- AURA Health Care
- Exchange
- BMBL Nasdaq
- AURA Nasdaq
- Market Cap
- BMBL 446.5M
- AURA 396.8M
- IPO Year
- BMBL 2021
- AURA 2021
- Fundamental
- Price
- BMBL $8.22
- AURA $7.23
- Analyst Decision
- BMBL Hold
- AURA Strong Buy
- Analyst Count
- BMBL 16
- AURA 6
- Target Price
- BMBL $6.36
- AURA $22.33
- AVG Volume (30 Days)
- BMBL 2.6M
- AURA 205.3K
- Earning Date
- BMBL 08-06-2025
- AURA 08-07-2025
- Dividend Yield
- BMBL N/A
- AURA N/A
- EPS Growth
- BMBL N/A
- AURA N/A
- EPS
- BMBL N/A
- AURA N/A
- Revenue
- BMBL $1,050,969,000.00
- AURA N/A
- Revenue This Year
- BMBL N/A
- AURA N/A
- Revenue Next Year
- BMBL N/A
- AURA N/A
- P/E Ratio
- BMBL N/A
- AURA N/A
- Revenue Growth
- BMBL N/A
- AURA N/A
- 52 Week Low
- BMBL $3.55
- AURA $4.35
- 52 Week High
- BMBL $9.72
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- BMBL 73.99
- AURA 61.99
- Support Level
- BMBL $6.80
- AURA $6.72
- Resistance Level
- BMBL $7.51
- AURA $7.15
- Average True Range (ATR)
- BMBL 0.38
- AURA 0.36
- MACD
- BMBL 0.15
- AURA 0.04
- Stochastic Oscillator
- BMBL 81.65
- AURA 98.45
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.